IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q2 2017 Holdings

Filed 2017-08-14 | 27 holdings | $27.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beigene LTD(ONC)SPONSORED ADR07725L102$27.0M600,00098.6%
Avexis IncCOM05366U100$65.7K800,0000.2%
Clovis Oncology Inc(CLVSEUR)COM189464100$46.8K500,0000.2%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$46.3K1,000,0000.2%
Medicines CompanyCOM584688105$46.2K1,215,0000.2%
Macrogenics Inc(MGNX)COM556099109$37.0K2,115,0000.1%
PTC Therapeutics Inc(PTCT)COM69366J200$31.2K1,700,0000.1%
Medicines CompanyCallCALL584688905$20.2K530,6000.1%
Blueprint Medicines Corp(2L9)COM09627Y109$12.7K250,0000.0%
Incyte Corp(INCY)COM45337C102$12.6K100,0000.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$11.0K629,1790.0%
Puma Biotechnology Inc(PBYI)COM74587V107$8.7K100,0000.0%
LA Jolla Pharmaceutical Co(LJPC)COM PAR $.0001 2503459604$8.0K267,5000.0%
Aquinox Pharmaceuticals IncCOM03842B101$7.4K525,0000.0%
Strongbridge Biopharma PLCSHS USDG85347105$6.7K940,0000.0%
Seattle Genetics IncCOM812578102$6.5K125,0000.0%
Kura Oncology Inc(KURA)COM50127T109$5.0K533,2510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$3.8K1,037,9940.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$3.3K234,2200.0%
Barclays BK PLCIPATH S&P 500 VIX06740Q252$3.2K250,0000.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$2.8K1,025,0000.0%
Belleropon Therapeutics Inc(BLPHEUR)COM078771102$2.5K1,857,1430.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$2.4K425,0000.0%
Nabriva Therapeutics AGSPONSORED ADR62957M104$1.9K176,7100.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.1K138,3310.0%
Onconova Therapeutics IncCOM NEW68232V306$654302,8860.0%
Onconova Therapeutics Inc*W EXP 07/11/20268232V116$109241,6440.0%